Saturday, November 23, 2024
HomeTagsIASO Biotherapeutics

IASO Biotherapeutics

IASO Biotherapeutics’ Equecabtagene Autoleucel, the World’s First CAR-T for Treatment of NMOSD, Receives IND Application Acceptance by NMPA

IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, announced that China's National...

Sana Biotech, IASO Biotherapeutics, and Innovent Biologics Sign Agreement for BCMA CAR Construct

Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in...

IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting

IASO Biotherapeutics, a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and Innovent Biologics, Inc., a world-class biopharmaceutical company that develops,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics